CAMEO+ eventCORPORATE2026-05-06🇫🇷
Signadori Bio raises €11 million seed round to advance solid tumor platform
source: Signadori Bio SAS
On 2026-05-06, Signadori Bio SAS announced the successful completion of a €11.1 million seed extension financing round. The preclinical biopharmaceutical company said the proceeds will support its solid tumour platform, lead programme SiB-2101, and team expansion.
0.12Significance1.0Magnitude0.1Systemic0.2Market1Articles
Location
FranceEuropeFranceEurope46.228, 2.214
Story Links